GeneDx announced GenomeDx Prenatal™, a whole genome sequencing test that delivers fast, comprehensive insights when fetal ...

Globally, NIPT is seeing increasing uptake across hospitals and diagnostic laboratories as demand for safer, early fetal screening rise and prenatal care pathways continue to evolve globally helping ...

Genedx Holding Corp. launched Genomedx Prenatal, its whole genome sequencing test, to provide more definitive diagnoses of the causes of fetal abnormalities identified by ultrasound. By combining the ...

During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or has certain genetic disorders or anomalies. This information can help ...

As prenatal genetic testing becomes more common, experts explain what these tests can and cannot predict, how parents should ...

Verified Market Research® is pleased to announce the release of its latest market research report on the “Non-Invasive Prenatal Testing Market – Trends, Opportunities, and Forecasts”, offering ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

NEW YORK (Reuters Health) - Normally, parents who want to know the sex of their baby before it's born find out through ultrasound done in the second trimester. A blood test that can be done early in ...

LONDON - JULY 18: (Photo illustration by Daniel Berehulak/Getty Images) Over time, non-invasive screening studies were developed that were easier and safer for pregnant patients. Early versions of ...